August Debouzy

Attorneys-at-law · Patent attorneys

13 UPC Representatives · 3 SEP Litigators

 France

Firm Website

Short self-description

August Debouzy is an independent full-service law firm in Paris and Brussels. Its patent team is composed of a balanced mix of attorneys-at-law and patent attorneys. Most of them have a dual legal and technical qualification and are qualified as European Patent Attorneys.

Main practice areas: M&A, Financing, Tax Law, Real Estate, IT and Data, Patent, IP, Competition, Retail and Consumer Law, Compliance, Dispute Resolution, Contract and more.

Industry/technology focus: Mechanical engineering; physics and general engineering; electrical engineering; electronics; information and communication technology; automotive; aerospace; green tech and sustainable technologies; material science; chemistry; pharmaceutics; life sciences including biotech; medical devices and e-health.

UPC-related services: Patent enforcement; defense against infringement claims; proactive revocation claims; defense against revocation claims; bring and pursue notice of opposition in EPO; defense in EPO opposition proceedings; unitary patent appeals from EPO; opt-outs and withdrawals.

August Debouzy has practiced in five CFI divisions, and before the CoA.

SEP-related services: Advice on FRAND negotiations for implementers; defense against SEP infringement claims; bring revocation claims against SEPs (including EPO opposition, PTAB, etc.); bring antitrust-based FRAND claims; defense against contract-based FRAND claims.

Rankings and awards

  • CHAMBERS FRANCE 2026 – Intellectual property: patent, Band 1.
  • LEGAL 500 EMEA 2026 – Intellectual property: patent, Tier 1.
  • LEGAL 500 EMEA 2026 – Industry focus: Healthcare and life sciences, Tier 2.
  • JUVE PATENT UPC 2026:
    – Firm rankings : Tier 3/5.
    – Leading Individuals: Grégoire Desrousseaux.
  • JUVE PATENT FRANCE 2026
    – Firm Rankings: Tier 1/5.
    – Leading individuals in Litigation: Grégoire Desrousseaux, François Pochart.
    – Ones to watch in Litigation: Pierre-Olivier Ally.
  • IAM 2026:
    – UPC: Silver (Tier 2/3)
    – France, Firms – Litigation: gold.
    – France, Firms – Litigation: Gold (Tier 1/3).
    – France, Firms – Prosecution: Bronze (Tier 3/3).
    – France, Firms – Transactions: Recommended European Patent Office: Bronze (Tier 3/3).
  • IPstars 2026:
    – Patent disputes: Tier 1.
    – UPC litigation: recommended.
    – Patent stars: Grégoire Desrousseaux, François Pochart, Lionel Martin.
    – Rising star: Pierre-Olivier Ally.

UPC achievements

Defended first-instance final judgments or provisional measures decisions on appeal

  • Sibio Technology Limited v. Abbott Diabetes Care Inc. (July 21, 2025 – CD Paris).

Successful infringement assertions (main proceedings)

  • Helwett-Packard Development Company, L.P v. Lama France (November 13, 2024 – Paris LD).

Successful infringement defenses (main proceedings)

  • DexCom, Inc v. Abbott Logistics B.V. et al. (December 11, 2024 – Paris LD).
  • DexCom, Inc. v. Abbott Laboratories et al. (July 31, 2024 – Munich LD).

Invalidated patents through revocation (counter)claim or EPO opposition

  • DexCom, Inc v. Abbott Logistics B.V. et al. (December 11, 2024 – Paris LD).
  • DexCom, Inc. v. Abbott Laboratories et al. (July 31, 2024 – Munich LD).

Defended patents against revocation (counter)claim or EPO opposition

  • Sibio Technology Limited v. Abbott Diabetes Care Inc. (July 21, 2025 – The Hague LD).

Obtained provisional measures (preliminary injunctions)

Settlements

  • Smart Trike MNF. PTE. LTD., Yoram Bar-On v Brandline Group SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ (August 19, 2025 – CD Paris).
  • Helwett-Packard Development Company, L.P. v. Lama France (July 24, 2025 – CoA, UPC_CoA_24/2025 and UPC_CoA_23/2025).
  • Xingmai Innovation Technology (Suzhou) Co., Ltd. V. Maytronics Ltd. (June 12, 2025 – CD Paris).
  • DexCom, Inc. v. Abbott Laboratories et al. (January 27, 2025 – CoA).
  • Dexcom, Inc. V. Abbott Laboratories et al. (January 17, 2025 – Paris LD).
  • Abbott Diabetes Care Inc. v. Dexcom Inc. Et al.(January 16, 2025 – Paris LD).
  • DexCom, Inc v Abbott Laboratories et al (January 7, 2025 – Dusseldorf LD).
  • ICPillar LLC, ARM Limited et al. (December 12, 2024 – Paris LD).
  • I.G.B. S.r.l. v Unilever France (November 14, 2024 – Paris LD).
  • Canè S.p.A. v. France Développement Electronique (July 26, 2024 – Paris LD).

SEP achievements

Won technical infringement rulings over SEPs

Defended against SEP-based infringement allegations

Settlements prior to decisions